• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性和遗传性乳腺癌中胸苷酸合成酶基因(TYMS)多态性

Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer.

作者信息

da Silva Nogueira José, de Lima Marson Fernando Augusto, Sílvia Bertuzzo Carmen

机构信息

Department of Genetics, Faculty of Medical Sciences, University of Campinas, P.O. Box: 6111, Campinas, SP 13081-970, Brazil.

出版信息

BMC Res Notes. 2012 Dec 6;5:676. doi: 10.1186/1756-0500-5-676.

DOI:10.1186/1756-0500-5-676
PMID:23217244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3547688/
Abstract

BACKGROUND

Breast cancer (BC) is a genetic disorder characterized by growth and proliferation of breast cells in a disorderly. In Brazil, there are approximately 49.240 new cases of BC, every year. The BC etiology is still poorly understood. The BC can be sporadic (SBC) or hereditary (HBC). Recent studies have correlated gene polymorphisms with the BC, such as alterations in thymidylate synthase gene (TYMS), which are used to improve diagnosis and prevention of the disease. Polymorphisms in the TYMS gene 5'-UTR region, usually present reps double (2R) and/or triple (3R). Studies have shown that homozygous 3R/3R is overexpressed compared with 2R/2R genotype, and these polymorphic variations may contribute to individual susceptibility to the development of BC. In this context, the objective of this study was to evaluate the frequency of the TYMS 2R and 3R polymorphisms, comparing genotypic and allelic distribution with SBC and HBC patients.

METHODS

In this study we included a total of 204 subjects, 70 with BC (33 with SBC, and 37 with HBC) and 134 healthy subjects (controls). The Polymerase Chain Reaction was the method used.

RESULTS

Results demonstrated a high frequency of the 3R allele at BC, SBC, and HBC groups. The frequency of genotype 2R/3R was significantly higher in BC group. This work showed association between the 2R/3R variants (OR = 4.14, CI95% = 1.77-9.71) in the development of SBC, and 2R/2R (OR = 0.233, CI95% = 1.63-7.65) and 2R/3R (OR = 3.53, CI95% = 0.06-0.81) for developing HBC. To BC, there was association with the genotype 2R/3R (OR: 3.79, CI95% = 2.03-7.08).

CONCLUSION

Our results show relation to the development of BC in association with the analyzed polymorphisms.

摘要

背景

乳腺癌(BC)是一种遗传性疾病,其特征是乳腺细胞无序生长和增殖。在巴西,每年约有49240例新的乳腺癌病例。乳腺癌的病因仍知之甚少。乳腺癌可分为散发性(SBC)或遗传性(HBC)。最近的研究将基因多态性与乳腺癌相关联,例如胸苷酸合成酶基因(TYMS)的改变,这些改变可用于改善疾病的诊断和预防。TYMS基因5'-UTR区域的多态性通常呈现重复双倍(2R)和/或重复三倍(3R)。研究表明,与2R/2R基因型相比,纯合3R/3R过度表达,这些多态性变异可能导致个体对乳腺癌发生的易感性。在此背景下,本研究的目的是评估TYMS 2R和3R多态性的频率,比较SBC和HBC患者的基因型和等位基因分布。

方法

本研究共纳入204名受试者,70名乳腺癌患者(33名SBC患者和37名HBC患者)以及134名健康受试者(对照组)。采用聚合酶链反应方法。

结果

结果显示,在乳腺癌、SBC和HBC组中3R等位基因频率较高。BC组中2R/3R基因型频率显著更高。这项研究表明,2R/3R变异(OR = 4.14,CI95% = 1.77 - 9.71)与SBC的发生相关,而2R/2R(OR = 0.233,CI95% = 1.63 - 7.65)和2R/3R(OR = 3.53,CI95% = 0.06 - 0.81)与HBC的发生相关。对于乳腺癌,与2R/3R基因型相关(OR:3.79,CI95% = 2.03 - 7.08)。

结论

我们的结果表明,所分析的多态性与乳腺癌的发生有关。

相似文献

1
Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer.散发性和遗传性乳腺癌中胸苷酸合成酶基因(TYMS)多态性
BMC Res Notes. 2012 Dec 6;5:676. doi: 10.1186/1756-0500-5-676.
2
Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.胸苷酸合成酶基因多态性可预测接受基于5-氟尿嘧啶化疗的结直肠癌患者的毒性。
Clin Cancer Res. 2004 Sep 1;10(17):5880-8. doi: 10.1158/1078-0432.CCR-04-0169.
3
2R of thymidylate synthase 5'-untranslated enhanced region contributes to gastric cancer risk: a meta-analysis.胸苷酸合成酶5'-非翻译增强区域的2R与胃癌风险相关:一项荟萃分析。
Asian Pac J Cancer Prev. 2012;13(5):1923-7. doi: 10.7314/apjcp.2012.13.5.1923.
4
Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.胸苷酸合成酶基因多态性与中国人群乳腺癌易感性:一项病例对照分析。
BMC Cancer. 2006 May 25;6:138. doi: 10.1186/1471-2407-6-138.
5
Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patients.胸苷酸合成酶基因多态性对乳腺癌患者 5-FU 反应的影响。
Cancer Biomark. 2010;6(2):83-93. doi: 10.3233/CBM-2009-0121.
6
Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.胸苷酸合成酶多态性与血液系统恶性肿瘤风险:一项荟萃分析。
Leuk Lymphoma. 2012 Jul;53(7):1345-51. doi: 10.3109/10428194.2011.649477. Epub 2012 Jan 31.
7
Association between polymorphisms in the thymidylate synthase gene and risk of breast cancer in a Mexican population.胸苷酸合成酶基因多态性与墨西哥人群乳腺癌风险之间的关联。
Genet Mol Res. 2014 Oct 27;13(4):8749-56. doi: 10.4238/2014.October.27.16.
8
Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma.Tyms基因的双倍(2R)和三倍重复(3R)会增加人类口腔鳞状细胞癌的发病风险。
Mol Biol Rep. 2014 Dec;41(12):7737-42. doi: 10.1007/s11033-014-3494-x. Epub 2014 Oct 24.
9
A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case-control study.POLQ基因中的一种DNA修复变异(c.-1060A>G)与遗传性乳腺癌患者相关:一项病例对照研究。
BMC Cancer. 2014 Nov 19;14:850. doi: 10.1186/1471-2407-14-850.
10
Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.胸苷酸合成酶基因多态性与直肠癌术前放化疗肿瘤反应的相关性:一项系统评价和Meta分析
Pharmacogenomics J. 2017 Jun;17(3):265-273. doi: 10.1038/tpj.2016.11. Epub 2016 Mar 22.

引用本文的文献

1
Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer.叶酸代谢和 DNA 甲基化相关基因多态性与头颈部癌症风险的关系。
Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3751-3759. doi: 10.31557/APJCP.2020.21.12.3751.
2
3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.胸苷酸合成酶基因 3'UTR 多态性增加了前癌性宫颈病变持续存在的风险。
BMC Cancer. 2020 Apr 15;20(1):323. doi: 10.1186/s12885-020-06811-7.
3
Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.基于网络的遗传分析揭示滤泡性甲状腺癌和滤泡状甲状腺腺瘤之间的细胞通路差异。
Int J Environ Res Public Health. 2020 Feb 20;17(4):1373. doi: 10.3390/ijerph17041373.
4
Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis.通过生物信息学分析筛选和鉴定肺鳞状细胞癌中的关键生物标志物
Oncol Lett. 2019 Nov;18(5):5185-5196. doi: 10.3892/ol.2019.10873. Epub 2019 Sep 16.
5
Thymidylate synthase predicts poor response to pemetrexed chemotherapy in patients with advanced breast cancer.胸苷酸合成酶可预测晚期乳腺癌患者对培美曲塞化疗反应不佳。
Oncol Lett. 2018 Sep;16(3):3274-3280. doi: 10.3892/ol.2018.8973. Epub 2018 Jun 15.
6
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.乳腺癌患者的基因多态性与对5-氟尿嘧啶、阿霉素和环磷酰胺化疗的反应
Oncotarget. 2016 Oct 11;7(41):66790-66808. doi: 10.18632/oncotarget.11053.
7
Predictive value of thymidylate synthase for the prognosis and survival of lung adenocarcinoma patients.胸苷酸合成酶对肺腺癌患者预后及生存的预测价值
Oncol Lett. 2015 Jan;9(1):252-256. doi: 10.3892/ol.2014.2658. Epub 2014 Nov 3.
8
Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer.头颈癌中TP53-微小RNA通路下游基因靶点的异常改变表达
Sci Rep. 2014 Sep 4;4:6280. doi: 10.1038/srep06280.

本文引用的文献

1
Reexamining a proposal: thymidylate synthase 5'-untranslated region as a regulator of translation efficiency.重新审视一个建议:胸苷酸合成酶 5'非翻译区作为翻译效率的调节剂。
Cancer Biol Ther. 2011 Oct 15;12(8):750-5. doi: 10.4161/cbt.12.8.16867.
2
SNP-SNP interactions between dNTP supply enzymes and mismatch DNA repair in breast cancer.乳腺癌中dNTP供应酶与错配DNA修复之间的单核苷酸多态性-单核苷酸多态性相互作用。
Proc Ohio Collab Conf Bioinform. 2009 Jun 15;2009:123-128. doi: 10.1109/OCCBIO.2009.25.
3
Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma.膳食叶酸摄入与头颈部鳞状细胞癌临床结局的关系。
Ann Oncol. 2012 Jan;23(1):186-192. doi: 10.1093/annonc/mdr057. Epub 2011 Apr 2.
4
The association between two polymorphisms in the TYMS gene and breast cancer risk: appraisal of a recent meta-analysis.
Breast Cancer Res Treat. 2011 Jul;128(1):289-90. doi: 10.1007/s10549-011-1390-9. Epub 2011 Feb 15.
5
Thymidylate synthase (TS) gene expression in primary lung cancer patients: a large-scale study in Japanese population.原发性肺癌患者胸苷酸合成酶 (TS) 基因表达:日本人群的大规模研究。
Ann Oncol. 2011 Aug;22(8):1791-7. doi: 10.1093/annonc/mdq730. Epub 2011 Feb 14.
6
Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.胸苷酸合成酶基因导向的新辅助放化疗治疗直肠腺癌患者。
J Clin Oncol. 2011 Mar 1;29(7):875-83. doi: 10.1200/JCO.2010.32.3212. Epub 2011 Jan 4.
7
The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis.TYMS 基因两个多态性与乳腺癌风险的关联:荟萃分析。
Breast Cancer Res Treat. 2011 Jul;128(1):203-9. doi: 10.1007/s10549-010-1314-0. Epub 2010 Dec 25.
8
Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer.核苷酸切除修复缺陷是散发性 I 期乳腺癌的内在特征。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21725-30. doi: 10.1073/pnas.0914772107. Epub 2010 Nov 30.
9
TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients.TS 基因多态性不是 III 期结肠癌患者对 5-FU 治疗反应的良好标志物。
Anal Cell Pathol (Amst). 2010;33(1):1-11. doi: 10.3233/ACP-CLO-2010-0526.
10
Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.胸苷酸合成酶基因多态性影响直肠癌患者术前氟尿嘧啶放化疗的反应。
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):669-76. doi: 10.1016/j.ijrobp.2010.06.049. Epub 2010 Oct 6.